Reply to Leonard P. Bokhorst and Berdine L. Heesterman's Words of Wisdom re: High-dose Radiotherapy and Risk-adapted Androgen Deprivation in Localised Prostate Cancer (DART 01/05): 10-Year Results of a Phase 3 Randomised, Controlled Trial. Eur Urol. 2022;82:441.

作者信息

Zapatero Almudena, Calvo Felipe A, Gonzalez San-Segundo Carmen, Alvarez Ana

机构信息

Department of Radiation Oncology, Hospital Universitario de La Princesa, Health Research Institute, Madrid, Spain.

Radiation Oncology Department, Hospital General Universitario Gregorio Marañón, Madrid, Spain; Radiation Oncology Department, Clínical Universitaria de Navarra, Madrid, Spain.

出版信息

Eur Urol. 2022 Dec;82(6):e177-e178. doi: 10.1016/j.eururo.2022.08.033. Epub 2022 Sep 15.

DOI:10.1016/j.eururo.2022.08.033

PMID:36115773

Abstract

摘要

相似文献

Reply to Leonard P. Bokhorst and Berdine L. Heesterman's Words of Wisdom re: High-dose Radiotherapy and Risk-adapted Androgen Deprivation in Localised Prostate Cancer (DART 01/05): 10-Year Results of a Phase 3 Randomised, Controlled Trial. Eur Urol. 2022;82:441.

Eur Urol. 2022 Dec;82(6):e177-e178. doi: 10.1016/j.eururo.2022.08.033. Epub 2022 Sep 15.

Re: High-dose Radiotherapy and Risk-adapted Androgen Deprivation in Localised Prostate Cancer (DART 01/05): 10-Year Results of a Phase 3 Randomised, Controlled Trial.关于：局限性前列腺癌的大剂量放疗与风险适应性雄激素剥夺治疗（DART 01/05）：一项3期随机对照试验的10年结果。

Eur Urol. 2022 Oct;82(4):441. doi: 10.1016/j.eururo.2022.07.004. Epub 2022 Jul 25.

High-dose radiotherapy and risk-adapted androgen deprivation in localised prostate cancer (DART 01/05): 10-year results of a phase 3 randomised, controlled trial.局部前列腺癌的高剂量放疗与风险适应性雄激素剥夺治疗（DART 01/05）：一项3期随机对照试验的10年结果

Lancet Oncol. 2022 May;23(5):671-681. doi: 10.1016/S1470-2045(22)00190-5. Epub 2022 Apr 12.

Re: Loren K. Mell, Stephanie L. Pugh, Christopher U. Jones, et al. Effects of Androgen Deprivation Therapy on Prostate Cancer Outcomes According to Competing Event Risk: Secondary Analysis of a Phase 3 Randomised Trial. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2023.01.020.回复：洛伦·K·梅尔、斯蒂芬妮·L·普格、克里斯托弗·U·琼斯等人。根据竞争事件风险分析雄激素剥夺疗法对前列腺癌预后的影响：一项3期随机试验的二次分析。《欧洲泌尿外科杂志》。即将发表。https://doi.org/10.1016/j.eururo.2023.01.020

Eur Urol. 2023 Sep;84(3):e73-e74. doi: 10.1016/j.eururo.2023.04.037. Epub 2023 May 17.

Re: Bo Dai, Sheng Zhang, Fan-Ning Wan, et al. Combination of Androgen Deprivation Therapy with Radical Local Therapy Versus Androgen Deprivation Therapy Alone for Newly Diagnosed Oligometastatic Prostate Cancer : A Phase 2 Randomized Controlled Trial. Eur Urol Oncol 2022;5:519-25.

Eur Urol Oncol. 2023 Aug;6(4):451. doi: 10.1016/j.euo.2023.01.006. Epub 2023 Jan 25.

Re: Androgen deprivation therapy and radiotherapy in intermediate risk prostate cancer: A randomized phase III trial.回复：中危前列腺癌的雄激素剥夺疗法与放射疗法：一项随机III期试验

Eur J Cancer. 2022 May;167:164-165. doi: 10.1016/j.ejca.2022.01.041. Epub 2022 Mar 10.

Re: Liam Bourke, Stephen Gilbert, Richard Hooper, et al. Lifestyle changes for improving disease-specific quality of life in sedentary men on long-term androgen-deprivation therapy for advanced prostate cancer: a randomised controlled trial. Eur Urol 2014;65:865-72; Re: Daniel A. Galvão, Nigel Spry, James Denham, et al. A multicentre year-long randomised controlled trial of exercise training targeting physical functioning in men with prostate cancer previously treated with androgen suppression and radiation from TROG 03.04 RADAR. Eur Urol 2014;65:856-64; Re: Nancy L. Keating, Pang-Hsiang Liu, A. James O'Malley, Stephen J. Freedland, Matthew R. Smith. Androgen-deprivation therapy and diabetes control among diabetic men with prostate cancer. Eur Urol 2014;65:816-24; Re: Christina G. Jespersen, Mette Nørgaard, Michael Borre. Androgen-deprivation therapy in treatment of prostate cancer and risk of myocardial infarction and stroke: a nationwide Danish population-based cohort study. Eur Urol 2014;65:704-9.回复：利亚姆·伯克、斯蒂芬·吉尔伯特、理查德·胡珀等人。生活方式改变对接受晚期前列腺癌长期雄激素剥夺治疗的久坐男性特定疾病生活质量的改善作用：一项随机对照试验。《欧洲泌尿外科杂志》2014年；65：865 - 872；回复：丹尼尔·A·加尔瓦奥、奈杰尔·斯普里、詹姆斯·德纳姆等人。一项针对接受过雄激素抑制和放疗的前列腺癌男性进行的为期一年的多中心随机对照试验，该试验以运动训练改善身体机能为目标（来自TROG 03.04 RADAR研究）。《欧洲泌尿外科杂志》2014年；65：856 - 864；回复：南希·L·基廷、刘庞祥、A·詹姆斯·奥马利、斯蒂芬·J·弗里德兰、马修·R·史密斯。前列腺癌男性糖尿病患者中的雄激素剥夺治疗与血糖控制。《欧洲泌尿外科杂志》2014年；65：816 - 824；回复：克里斯蒂娜·G·耶斯佩森、梅特·诺尔加德、迈克尔·博勒。前列腺癌治疗中的雄激素剥夺治疗与心肌梗死和中风风险：一项基于丹麦全国人口的队列研究。《欧洲泌尿外科杂志》2014年；65：704 - 709。

Eur Urol. 2014 Sep;66(3):e51-2. doi: 10.1016/j.eururo.2014.04.018. Epub 2014 May 10.

Re: The Addition of Androgen Deprivation Therapy and Pelvic Lymph Node Treatment to Prostate Bed Salvage Radiotherapy (NRG Oncology/RTOG 0534 SPPORT): An International, Multicentre, Randomised Phase 3 Trial.回复：前列腺床挽救性放疗联合雄激素剥夺治疗及盆腔淋巴结治疗（NRG肿瘤学/放射治疗肿瘤学组0534 SPPORT）：一项国际多中心随机3期试验

Eur Urol. 2023 May;83(5):475. doi: 10.1016/j.eururo.2022.12.026. Epub 2023 Jan 4.

Words of Wisdom. Re: Androgen Deprivation Therapy plus Docetaxel and Estramustine Versus Androgen Deprivation Therapy Alone for High-risk Localised Prostate Cancer (GETUG 12): A Phase 3 Randomised Controlled Trial.智慧之言。关于：雄激素剥夺疗法联合多西他赛和雌莫司汀与单纯雄激素剥夺疗法治疗高危局限性前列腺癌（GETUG 12）：一项3期随机对照试验。

Eur Urol. 2015 Dec;68(6):1098-9. doi: 10.1016/j.eururo.2015.08.047.

Re: Rhonda L. Bitting, Patrick Healy, Daniel J. George, et al. Phase II Trial of Enzalutamide and Androgen Deprivation Therapy with Salvage Radiation in Men with High-risk Prostate-specific Antigen Recurrent Prostate Cancer: The STREAM Trial. Eur Urol Oncol 2021;4:948-54.回复：朗达·L·比廷、帕特里克·希利、丹尼尔·J·乔治等。恩杂鲁胺与雄激素剥夺疗法联合挽救性放疗用于高风险前列腺特异性抗原复发前列腺癌男性患者的II期试验：STREAM试验。《欧洲泌尿外科肿瘤学杂志》2021年；4：948 - 54。

Eur Urol Oncol. 2022 Aug;5(4):477-478. doi: 10.1016/j.euo.2022.03.002. Epub 2022 Mar 17.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验